OptiNose, Inc. (OPTN) Financials
OPTN Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 107.7 million | 194.3 million |
| 2023-09-30 | 101.4 million | 179.0 million |
| 2023-06-30 | 106.1 million | 175.7 million |
| 2023-03-31 | 114.9 million | 188.7 million |
OPTN Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 6.8 million | 979000 |
| 2023-09-30 | -4.6 million | 1.2 million |
| 2023-06-30 | -12.6 million | 1.5 million |
| 2023-03-31 | -10.5 million | 1.5 million |
OPTN Net Income
No data available :(
OPTN Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 73.7 million | - | 1.5 million |
| 2023-09-30 | 66.8 million | - | 1.1 million |
| 2023-06-30 | 71.3 million | - | 1.4 million |
| 2023-03-31 | 83.9 million | - | 1.6 million |
OPTN Shares Outstanding
OPTN Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 73000 | 1.3 million | 19.0 million | - |
| 2023-09-30 | 176000 | 1.3 million | 18.0 million | - |
| 2023-06-30 | 79000 | 951000 | 20.1 million | - |
| 2023-03-31 | 79000 | 1.8 million | 22.7 million | - |
OPTN Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 19.9 million | 2.3 million |
| 2023-09-30 | 19.8 million | 2.2 million |
| 2023-06-30 | 19.5 million | 2.6 million |
| 2023-03-31 | 11.8 million | 1.7 million |
OPTN
Price: $0.88
52 week price:
Earnings Per Share: -0.32 USD
P/E Ratio: -3.21
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 133800
Ebitda: -13.0 millionMarket Capitalization: 139.7 million